Apricus Biosciences, Inc. said it began a public offering of its common shares and warrants to buy common stock.
The San Diego-based biopharmaceutical company plans to use the net proceeds for working capital and general corporate purposes.
H.C. Wainwright & Co. is acting as exclusive placement agent for the offering.